博士、副教授。江苏省“六大高峰”人才。日本国立冈山大学博士，日本立命馆大学博士后，美国北卡罗莱纳大学访问学者。目前主要从事肿瘤护理、慢性病护理及健康教育研究。系统担任《健康教育学》授课工作。先后主持国家自然科学基金、江苏省高校自然科学基金等项目。近年以第一作者/通讯作者发表多篇SCI论文。

 

1.     Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs. Zhang X, Sun S, Miao Y, Yuan Y, Zhao W, Li H, Wei X, Huang C, Hu X, Wang B, Xu H, Zhang W, Gao X, Song J, Zheng J, Zhang Q.J Cancer Res Clin Oncol. 2022 Aug 12. doi: 10.1007/s00432-022-04248-y. Online ahead of print.PMID: 35962287

2.     Effectiveness of internet-based support interventions on patients with breast cancer: a systematic review and narrative synthesis. Huang Y, Li Q, Zhou F, Song J.BMJ Open. 2022 May 31;12(5):e057664. doi: 10.1136/bmjopen-2021-057664.PMID: 35641011 Free PMC article.

3.     A Novel Targeted Nanoparticle for Traumatic Brain Injury Treatment: Combined Effect of ROS Depletion and Calcium Overload Inhibition. Han Z, Han Y, Huang X, Ma H, Zhang X, Song J, Dong J, Li S, Yu R, Liu H.Adv Healthc Mater. 2022 Jun;11(11):e2102256. doi: 10.1002/adhm.202102256. Epub 2022 Feb 17.PMID: 35118827

4.     Combining DNA Vaccine and AIM2 in H1 Nanoparticles Exert Anti-Renal Carcinoma Effects via Enhancing Tumor-Specific Multi-functional CD8⁺ T-cell Responses. Chai D, Shan H, Wang G, Zhang Q, Li H, Fang L, Song J, Liu N, Zhang Q, Yao H, Zheng J.Mol Cancer Ther. 2019 Feb;18(2):323-334. doi: 10.1158/1535-7163.MCT-18-0832. Epub 2018 Nov 6.PMID: 30401695

5.     H1/pAIM2 nanoparticles exert anti-tumour effects that is associated with the inflammasome activation in renal carcinoma. Chai D, Liu N, Li H, Wang G, Song J, Fang L, Lu Z, Yao H, Zheng J.J Cell Mol Med. 2018 Nov;22(11):5670-5681. doi: 10.1111/jcmm.13842. Epub 2018 Aug 30.PMID: 30160343 Free PMC article.

6.     AIM2 is a potential therapeutic target in human renal carcinoma and suppresses its invasion and metastasis via enhancing autophagy induction. Chai D, Shan H, Wang G, Li H, Fang L, Song J, Zhang Q, Bai J, Zheng J.Exp Cell Res. 2018 Sep 15;370(2):561-570. doi: 10.1016/j.yexcr.2018.07.021. Epub 2018 Jul 18.PMID: 30031129

7.     The development of CAR design for tumor CAR-T cell therapy. Xu D, Jin G, Chai D, Zhou X, Gu W, Chong Y, Song J, Zheng J.Oncotarget. 2018 Jan 12;9(17):13991-14004. doi: 10.18632/oncotarget.24179. eCollection 2018 Mar 2.PMID: 29568411 Free PMC article. Review. 

8.     Discoidin domain receptor 1: New star in cancer-targeted therapy and its complex role in breast carcinoma. Jing H, Song J, Zheng J.Oncol Lett. 2018 Mar;15(3):3403-3408. doi: 10.3892/ol.2018.7795. Epub 2018 Jan 15.PMID: 29467865 Free PMC article.